启迪药业集团股份公司2025年半年度报告摘要

Core Viewpoint - The company has undergone significant changes in its shareholding structure due to the judicial auction of shares held by its controlling shareholder, which may lead to a change in control [5][7][10]. Group 1: Shareholding Changes - The controlling shareholder,启迪科服, had 58,606,962 shares auctioned due to a financial dispute with a bank, with the auction scheduled from July 14 to July 15, 2025 [5][6]. - The shares were successfully sold for approximately 1.007 billion yuan to 湖南赛乐仙, resulting in 湖南赛乐仙 holding 24.47% of the company's total shares post-auction [6][7]. Group 2: Financial Reporting and Auditing - The company plans to change its auditing firm from 立信 to 希格玛 for the 2025 fiscal year, following a thorough evaluation process [10][24]. - The board of directors approved the change in the auditing firm with unanimous support, indicating confidence in 希格玛's qualifications and experience [27][28]. - The new auditing firm, 希格玛, has a strong track record and meets the necessary regulatory requirements for auditing public companies [19][23].